Related Experiment Video
Updated: Jun 18, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
Integrase inhibitors: why do we need a new drug class for HIV therapy?
1Bonn University, Department of Medicine I, Sigmund-Freud-Str. 25, 53105 Bonn, Germany. juergen.rockstroh@ukb.uni-bonn.de
Abstract:
The introduction of integrase inhibitors as a new drug class for treatment of HIV have added a very potent and extremely well tolerated new treatment option to the HIV-armentarium. Particularly in patients with previously developed drug resistance, the availability of new active drugs offers great hope. Moreover, the in general excellent safety profile offers numerous opportunities for all lines of therapy and special patient populations. Clearly more data is needed to further explore and define the future role of integrase inhibitors in HIV-care.
Related Concept Videos
Inhibitors of Virion Maturation and Assembly
Retrovirus Life Cycles
Antiviral Nucleoside Inhibitors
Inhibitors of Viral Protein Synthesis
Size and Structure of Viral Genomes
Inhibitors Of Virion Release

